Emergex Vaccines Holding LTD.

Vaccine company

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $20K in lobbying spend across 16 quarterly filings, Emergex Vaccines Holding LTD is an active lobbying client. Their lobbying covers 1 issue area. Active from 2020 to 2023.

$20K
Total Spend
4
Years Active
1
Firms Hired
2
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2020$20K
2021$0
2022$0
2023$0

Issues Lobbied

MED

Lobbying Firms

The Conafay Group, LLC

Lobbyists

Julie PawelczykEvangeline Smith

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED

  • •Influenza research.
  • •Influenza and respiratory disease research
  • •Infectious disease, influenza and respiratory disease research

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

American Clinical Laboratory Assn
$23.9M total spend
American Association of Orthopaedic Surgeons
$14.7M total spend
Jazz Pharmaceuticals, INC.
$11.5M total spend
American Academy of Pediatrics
$8.4M total spend
Mayo Clinic
$7.3M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.